CureVac N.V. Ordinary Shares (CVAC) Stock: Buy, Sell, or Hold?
CVAC - CureVac N.V. Ordinary Shares
$4.66
-0.01 (-0.21%)
▼
5d:
+8.37%
30d:
-9.95%
90d:
-14.5%
HOLD
LOW Confidence
Analysis Updated: Jan 5, 2026 12:00 AM ET
Earnings: Apr 29, 2026
0d
Get Alerted When CVAC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CVAC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CVAC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CVAC is currently trading at $4.66, which is considered fair based on recent price action.
Technical Outlook: Technically, CVAC is in a strong downtrend. The price is approaching resistance at $4.68. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CVAC scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.38 (+15.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CVAC is in a strong downtrend. The price is approaching resistance at $4.68. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CVAC scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.38 (+15.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
54/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
78.9%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: Trading below Wall St target ($5.38)
- CAUTION: Bottoming setup, but lagging the sector by 24% over 20 days — wait for relative strength
Support & Resistance Levels
Support Level
$4.00
Resistance Level
$4.68
Current Trend
Strong Downtrend
Technical data as of
Jan 5, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.38
Wall Street Target
$5.38
(+15.6%)
Revenue Growth (YoY)
-89.0%
Earnings Growth (YoY)
24.0%
Profit Margin
182.1%
Share & Embed Analysis
Last updated: October 03, 2026 8:43 AM ET
Data refreshes hourly during market hours. Next update: 9:43 AM
Data refreshes hourly during market hours. Next update: 9:43 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CVAC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$92 | 46 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 65 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 76 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 42 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
10 analysts |
$70 | 68 BUY |
